School of Pharmacy & Technology Management, SVKM’S NMIMS Deemed-to-be University, Shirpur, Maharashtra 425405, India ...

Thus, polymorphism can affect the quality, safety, and efficacy of the drug products. (2) Imatinib is a drug used for certain types of cancer and is marketed as its mesylate salt. It is a tyrosine ...

Chris Cabell, MD MHS FACC Appointed President and Head of Research & Development ------ John Adams, PhD Appointed Chief Scientific ...

GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

Research Progress of c-Kit in Platinum-Resistant Ovarian Cancer. Journal of Biosciences and Medicines, 13, 404-412. doi: 10.4236/jbm.2025.132030 . According to the date from Chinese Center for Disease ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his life by 30 years.

Mr. Iwicki Brings Track Record of Operational Excellence and Significant Expertise in PAH and Cardiovascular Diseases ---- Amit Munshi ...

Out-of-pocket costs like deductibles and copays deter people with cancer from complying with treatment.This creates a ...

Inhibikase Therapeutics, Inc.’s IKT share price has surged by 18.46%, which has investors questioning if this is right time ...